Blastocyst transfer in patients with high progesterone in late follicular phase of the antagonist protocol: a prospective, randomized, open, parallel controlled study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067460

Enrollment

Unknown

Registered

2023-01-09

Start date

2023-02-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Group A:Fresh transfer

Group B:Frozen transfer

Eligibility

Sex/Gender

Female

Age

20 Years to 37 Years

Inclusion criteria

Inclusion criteria: ? Controlled ovarian stimulation protocol was antagonist; ? Infertile patients undergoing the first IVF/ICSI treatment cycle; ? the age of the woman was less than 38 years old; ? Plasma P=1.2ng/ml on hCG day; ? patients had at least one transferable or frozen blastocyst; ? Both husband and wife fully understand and voluntarily participate in the experimental project.

Exclusion criteria

Exclusion criteria: ? serum P=3ng/ml on hCG day; ? Untreated hydrosalpinx; ? uterine malformation; Adenomyosis, stage ? and ? endometriosis; ? endometrial abnormalities (intrauterine adhesions, endometrial polyps, chronic endometritis, submucosal myoma, etc.); ? any chromosome abnormality of the couple or preimplantation genetic testing (PGT) cycle; ? cancellation of fresh-cycle transplantation for prevention of OHSS or other uncontrolled endocrine diseases.

Design outcomes

Primary

Measure	Time frame
LIve birth rate;	—

Countries

China

Contacts

Public ContactCai He

Northwest Women‘s and Children's Hospital

caihe@bjmu.edu.cn13581613908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026